Antibody-drug conjugate publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing ADC drug development

Antibody-drug conjugates are an exciting advance in cancer therapeutics. Read about Fortrea's oncology team contributions to ADC peer-reviewed journal articles.

Connect with us

We’ve been driving innovation with our tailored clinical solutions for 30+ years. Let’s connect.

I am interested in

* denotes required fields

Service Interest(s)

Clinical Pharmacology Services

Clinical Services-Phase I

Clinical Services-Phase II-IV

Medical Devices or Diagnostics

Functional Service Provider (FSP) Solutions

Market Access Strategy/Consulting

Pharmacovigilance/Safety Services

Regulatory Strategy/Consulting

Other Solutions

Upload RFP

(Word, PDF, PPT, Excel, Image)
One file only.
60 MB limit.
Allowed types: gif, jpg, jpeg, png, bmp, txt, rtf, html, pdf, doc, docx, ppt, pptx, xls, xlsx, xml.

First Name*

Last Name*

Job Title*

Company*

Business Email*

Business Phone

Country HQ*

State

Description*

I agree to receive other communications from Fortrea Inc

I agree to be contacted about products and services and receive other communications from Fortrea Inc. Please review Fortrea's Privacy Policy for further information. By submitting below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

By clicking submit below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

Explore Careers at Fortrea

Join our Site Network
Submit a Site Payment Inquiry

Learn more about participating in a Fortrea Clinical Trial